Section Arrow
RLYB.NASDAQ
- Rallybio Corp
(Financial Status)
Quotes are at least 15-min delayed:2025/09/05 18:01 EDT
After Hours
Last
 0.5965
-0.0121 (-1.99%)
Bid
0.57
Ask
0.617
High 0.617 
Low 0.5964 
Volume 132 
Regular Hours
Last
 0.6086
+0.0226 (+3.86%)
Day High 
0.615 
Prev. Close
0.586 
1-M High
0.65 
Volume 
293.35K 
Bid
0.57
Ask
0.617
Day Low
0.58 
Open
0.6 
1-M Low
0.4 
Market Cap 
24.49M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.58 
20-SMA 0.57 
50-SMA 0.49 
52-W High 1.2401 
52-W Low 0.2201 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.93/-0.97
Enterprise Value
24.49M
Balance Sheet
Book Value Per Share
1.10
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
636.00K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GNPXGenprex0.2295+0.0738+47.40%0.18PE
After Hours 0.209 -0.0205 -8.93%
ADAPAdaptimmune Therapeutics plc0.041-0.01-19.61%-- 
After Hours 0.0427 +0.0017 +4.15%
NUVBNuvation Bio3.9+0.48+14.04%-- 
After Hours 3.92 +0.02 +0.51%
KLTOKlotho Neurosciences Inc0.4851-0.0099-2.00%-- 
After Hours 0.4738 -0.0113 -2.33%
IOVAIovance Biotherapeutics2.49+0.29+13.18%-- 
After Hours 2.49 0 0.00%
Quotes are at least 15-min delayed:2025/09/05 18:01 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.